Asembia Appoints Specialty Pharmacy Veteran David Skomo as Chief Executive Officer

Asembia has announced the appointment of David Skomo as its new Chief Executive Officer, succeeding co-founder Lawrence Irene. According to the announcement published on October 29, 2026, Skomo brings more than three decades of experience in specialty pharmacy, pharmacy benefit management (PBM), and pharmaceutical services.

Leadership Transition and Strategy

• New Leadership: David Skomo assumes the role of CEO, taking over from co-founder Lawrence Irene.
• Executive Background: Skomo previously served as Chief Operating Officer and Division President of HealthDyne at WellDyne, with prior senior roles at OptumRx, CVS, and Diplomat.
• Growth Focus: Skomo's tenure will focus on investing in technology, marketing, and operational initiatives, alongside commercial capabilities and strategic acquisitions.

About Asembia

Headquartered in Florham Park, New Jersey, Asembia provides technology-enabled commercialization solutions for the specialty pharmaceutical industry. The company's offerings include patient support HUB services, specialty distribution, data services, pharmacy software, and group purchasing organization (GPO) solutions designed to improve access to therapy for patients, prescribers, pharmacies, and pharmaceutical manufacturers.

Practical Implications and Verification

Stakeholders and industry participants can review the original announcement and verify corporate updates by visiting Asembia's official website at www.asembia.com or by contacting company media representatives such as Bill Fitzgerald, Vice President of Marketing.